Inhibition of Na + /K + - and Ca 2+ -ATPase activities by phosphotetradecavanadate

dc.contributor.authorFraqueza, G.
dc.contributor.authorFuentes, J.
dc.contributor.authorKrivosudský, L.
dc.contributor.authorDutta, S.
dc.contributor.authorMal, S.S.
dc.contributor.authorRoller, A.
dc.contributor.authorGiester, G.
dc.contributor.authorRompel, A.
dc.contributor.authorAureliano, M.
dc.date.accessioned2026-02-05T09:29:48Z
dc.date.issued2019
dc.description.abstractPolyoxometalates (POMs)are promising inorganic inhibitors for P-type ATPases. The experimental models used to study the effects of POMs on these ATPases are usually in vitro models using vesicles from several membrane sources. Very recently, some polyoxotungstates, such as the Dawson anion [P <inf>2</inf> W <inf>18</inf> O <inf>62</inf> ] 6? , were shown to be potent P-type ATPase inhibitors; being active in vitro as well as in ex-vivo. In the present study we broaden the spectrum of highly active inhibitors of Na + /K + -ATPase from basal membrane of epithelial skin to the bi-capped Keggin-type anion phosphotetradecavanadate Cs <inf>5.6</inf> H <inf>3.4</inf> PV <inf>14</inf> O <inf>42</inf> (PV <inf>14</inf> )and we confront the data with activity of other commonly encountered polyoxovanadates, decavanadate (V <inf>10</inf> )and monovanadate (V <inf>1</inf> ). The X-ray crystal structure of PV <inf>14</inf> was solved and contains two trans-bicapped ?-Keggin anions H <inf>x</inf> PV <inf>14</inf> O <inf>42</inf> (9-x)- . The anion is built up from the classical Keggin structure [(PO <inf>4</inf> )@(V <inf>12</inf> O <inf>36</inf> )]capped by two [VO]units. PV <inf>14</inf> (10 ?M)exhibited higher ex-vivo inhibitory effect on Na + /K + -ATPase (78%)than was observed at the same concentrations of V <inf>10</inf> (66%)or V <inf>1</inf> (33%). Moreover, PV <inf>14</inf> is also a potent in vitro inhibitor of the Ca 2+ -ATPase activity (IC <inf>50</inf> 5 ?M)exhibiting stronger inhibition than the previously reported activities for V <inf>10</inf> (15 ?M)and V <inf>1</inf> (80 ?M). Putting it all together, when compared both P-typye ATPases it is suggested that PV <inf>14</inf> exibited a high potential to act as an in vivo inhibitor of the Na + /K + -ATPase associated with chloride secretion. © 2019 The Authors
dc.identifier.citationJournal of Inorganic Biochemistry, 2019, 197, , pp. -
dc.identifier.issn1620134
dc.identifier.urihttps://doi.org/10.1016/j.jinorgbio.2019.110700
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/24451
dc.publisherElsevier Inc. usjcs@elsevier.com
dc.subjectadenosine triphosphatase (calcium)
dc.subjectadenosine triphosphatase (potassium sodium)
dc.subjectadenosine triphosphatase inhibitor
dc.subjectanion
dc.subjectdecavanadate
dc.subjectinorganic acid
dc.subjectmonovanadate
dc.subjectouabain
dc.subjectphosphotetradecavanadate
dc.subjectunclassified drug
dc.subjectvanadium derivative
dc.subjectenzyme inhibitor
dc.subjectvanadic acid
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectbasement membrane
dc.subjectcomparative effectiveness
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectcrystal structure
dc.subjectdrug efficacy
dc.subjectdrug potency
dc.subjectenzyme activity
dc.subjectenzyme inhibition
dc.subjectex vivo study
dc.subjectIC50
dc.subjectin vitro study
dc.subjectnonhuman
dc.subjectsarcoplasmic reticulum
dc.subjectskin epithelium
dc.subjectchemistry
dc.subjecthuman
dc.subjectmetabolism
dc.subjectsynthesis
dc.subjectX ray crystallography
dc.subjectCalcium-Transporting ATPases
dc.subjectCrystallography, X-Ray
dc.subjectEnzyme Inhibitors
dc.subjectHumans
dc.subjectSodium-Potassium-Exchanging ATPase
dc.subjectVanadates
dc.titleInhibition of Na + /K + - and Ca 2+ -ATPase activities by phosphotetradecavanadate

Files

Collections